A Medical Device Daily

ContraMed (Charlotte, North Carolina) reported that it has received U.S. Patent No. 7,621,276 Intrauterine Fallopian Tube Occlusion Device which covers the company's methods for delivering an occlusion device for actively occluding the orifices of fallopian tubes. This technology allows for a single in-office minimally invasive surgical procedure. This patent also allows for the device to deliver medication or therapeutic agents to the uterine cavity.

ContraMed also reported that is has received a notice of allowance for U.S. patent application 11/884,027 Intrauterine Fallopian Tube Occlusion Device and method for use which covers an occlusion device for actively occluding the orifices of the fallopian tubes using the shape of the uterine cavity as a guide.

Beyond the newly reported intellectual property, ContraMed said that it has tested its proprietary devices with impressive pilot clinical study results.